Skip to main content
# Title Department Research Member Research Year
151 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
152 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Ayat allah Ali yousseif 2021
153 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2021
154 The utility of Multi-Detector Computed Tomography criteria after neoadjuvant therapy in Borderline Resectable Pancreatic cancer: Prospective, bi-institutional study Department of Radiology Dr. Haisam Ahmed Samy Aly Atta 2021
155 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2021
156 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Mohamed Ismail Omar Ali 2021
157 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Ali Zedan Tohamy mohammed 2021
158 Assessment of Humoral Immune Recovery in Children with Hematological malignancies after Completion of Chemotherapy Department of Pediatric Oncology Rania Taha Mohammed Ahmed 2021
159 The role of quantitative computed tomography perfusion in the assessment of colorectal thickening Department of Radiology Marwa Ali Mohammed Abdel fattah 2021
160 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021